We are live on
!
Find out more
BFC
Blue Fin Capital Portfolio holdings
AUM
$692M
1-Year Est. Return
27.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.06%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$273M
AUM Growth
+$8.31M
(+3.1%)
Cap. Flow
-$3.08M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
42.09%
Holding
133
New
9
Increased
18
Reduced
81
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.29M |
| 2 |
Chevron
CVX
|
+$773K |
| 3 |
Brookfield Asset Management
BAM
|
+$619K |
| 4 |
Qualcomm
QCOM
|
+$601K |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$577K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield
BN
|
+$741K |
| 2 |
NextEra Energy
NEE
|
+$701K |
| 3 |
Apple
AAPL
|
+$696K |
| 4 |
CrowdStrike
CRWD
|
+$663K |
| 5 |
PayPal
PYPL
|
+$635K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 12.11% |
| 4 | Communication Services | 6.46% |
| 5 | Consumer Discretionary | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Russell 3000 ETF
IWV
$20.3B
| $3.05M | 1.12% |
13,803
+1
| +0% | +$222 |
|
27
Blackrock
BLK
$175B
| $2.96M | 1.09% |
4,180
-65
| -2% | -$43.4K |
|
|
28
NextEra Energy
NEE
$182B
| $2.89M | 1.06% |
34,529
-8,676
| -20% | -$701K |
|
29
Home Depot
HD
$347B
| $2.82M | 1.03% |
8,928
-178
| -2% | -$54.2K |
|
30
Adobe
ADBE
$102B
| $2.8M | 1.02% |
8,311
-1,014
| -11% | -$324K |
|
31
CVS Health
CVS
$133B
| $2.57M | 0.94% |
27,555
-259
| -0.9% | -$25K |
|
32
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $2.56M | 0.94% |
67,629
-3,075
| -4% | -$113K |
|
33
Pfizer
PFE
$145B
| $2.39M | 0.88% |
46,701
-562
| -1% | -$26.9K |
|
34
Northrop Grumman
NOC
$78.4B
| $2.39M | 0.87% |
4,377
-32
| -0.7% | -$16.7K |
|
|
35
Brookfield
BN
$109B
| $2.36M | 0.86% |
112,521
-33,039
| -23% | -$741K |
|
36
AbbVie
ABBV
$431B
| $2.31M | 0.85% |
14,281
+42
| +0.3% | +$6.44K |
|
37
Stryker
SYK
$129B
| $2.17M | 0.79% |
8,859
-88
| -1% | -$20K |
|
38
Abbott
ABT
$182B
| $2.09M | 0.77% |
19,080
-268
| -1% | -$27.8K |
|
39
Alphabet (Google) Class C
GOOG
$4.59T
| $2.04M | 0.75% |
23,045
-212
| -0.9% | -$20.2K |
|
40
TJX Companies
TJX
$174B
| $1.74M | 0.64% |
21,887
+55
| +0.3% | +$4.06K |
|
41
Accenture
ACN
$104B
| $1.72M | 0.63% |
6,461
-235
| -4% | -$65K |
|
42
iShares Core US Aggregate Bond ETF
AGG
$138B
| $1.68M | 0.61% |
17,302
-465
| -3% | -$45K |
|
43
Procter & Gamble
PG
$345B
| $1.61M | 0.59% |
10,609
-194
| -2% | -$27.2K |
|
|
44
Chevron
CVX
$379B
| $1.6M | 0.59% |
8,901
+4,432
| +99% | +$773K |
|
45
PepsiCo
PEP
$190B
| $1.58M | 0.58% |
8,766
-210
| -2% | -$37.5K |
|
46
Bank of America
BAC
$440B
| $1.57M | 0.57% |
47,354
-62
| -0.1% | -$2.14K |
|
47
Coca-Cola
KO
$372B
| $1.52M | 0.56% |
23,863
-772
| -3% | -$46.6K |
|
48
iShares Biotechnology ETF
IBB
$9.39B
| $1.48M | 0.54% |
11,293
-275
| -2% | -$35.5K |
|
49
Amgen
AMGN
$210B
| $1.47M | 0.54% |
5,597
-314
| -5% | -$84.2K |
|
50
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $1.43M | 0.53% |
30,715
-463
| -1% | -$21.1K |
|
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Blue Fin Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Blue Fin Capital held 133 positions worth $273M, up 3.1% from $265M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Blue Fin Capital's Q4 2022 filing shows 9 new, 18 increased, 81 reduced and 5 closed positions. Its largest new stake was Brookfield Asset Management: 20,560 shares worth $589K. The largest sale was Brookfield, an estimated $741K.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Blue Fin Capital's largest Q4 2022 buy was Brookfield Asset Management: 20,560 shares worth $589K.
- Blue Fin Capital added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2022, an estimated $2.29M increase.
- Blue Fin Capital's biggest Q4 2022 reduction was Brookfield, cutting an estimated $741K.
- Blue Fin Capital fully exited Generac Holdings in Q4 2022, selling an estimated $335K.
- Blue Fin Capital's ten largest holdings make up 42% of its $273M portfolio in Q4 2022.
- Blue Fin Capital opened 9 new positions and closed 5 in Q4 2022.
- Blue Fin Capital's portfolio value rose 3.1% quarter-over-quarter to $273M.
Based on Blue Fin Capital's 13F filing for Q4 2022, filed 23 Jan 2023.